NCT05643534Phase 3Completed

Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

Study sponsor: Ardelyx

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-08-20Actual
Enrollment · participants180Actual
Source updated2026-09-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 1 Sep 2026. After: 20 Aug 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 1 Jun 2026. After: 1 Sep 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Primary completion date changed

Before: 31 Dec 2025. After: 1 Jun 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview